HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
The role of HER-2 expression as a prognostic factor in gastric cancer (GC) is still controversial. The aim of the study was to asses HER-2 status, its correlations with clinicopathological parameters, and prognostic impact in GC patients. Tumor samples were collected from 78 patients who had undergo...
Saved in:
Main Authors: | Agnieszka Halon, Piotr Donizy, Przemyslaw Biecek, Julia Rudno-Rudzinska, Wojciech Kielan, Rafal Matkowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/2012/941259 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High Percentage of ADAM-10 Positive Melanoma Cells Correlates with Paucity of Tumor-Infiltrating Lymphocytes but Does Not Predict Prognosis in Cutaneous Melanoma Patients
by: Piotr Donizy, et al.
Published: (2015-01-01) -
The Clinicopathological Features and Prognostic Significance of HER2-Low in Early Breast Tumors Patients Prognostic Comparison of HER-Low and HER2-Negative Breast Cancer Stratified by Hormone Receptor Status
by: Sanaa Gamrani, et al.
Published: (2023-01-01) -
Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2-Positive Breast Cancer
by: Miaomiao Jia, et al.
Published: (2024-01-01) -
HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
by: Cathy B. Moelans, et al.
Published: (2009-01-01) -
Diagnostic Immunohistochemistry : theranostic and genomic application /
by: Dabbs, David J.
Published: (2014)